- Home
- QUBT vs CRNX Comparison
QUBT vs CRNX Comparison
Compare QUBT & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QUBT
- CRNX
- Stock Information
- Founded
- QUBT 2001
- CRNX 2008
- Country
- QUBT United States
- CRNX United States
- Employees
- QUBT N/A
- CRNX N/A
- Industry
- QUBT Computer Manufacturing
- CRNX Biotechnology: Pharmaceutical Preparations
- Sector
- QUBT Technology
- CRNX Health Care
- Exchange
- QUBT Nasdaq
- CRNX Nasdaq
- Market Cap
- QUBT 2.7B
- CRNX 2.8B
- IPO Year
- QUBT N/A
- CRNX 2018
- Fundamental
- Price
- QUBT $18.35
- CRNX $35.48
- Analyst Decision
- QUBT Strong Buy
- CRNX Strong Buy
- Analyst Count
- QUBT 3
- CRNX 7
- Target Price
- QUBT $20.33
- CRNX $74.33
- AVG Volume (30 Days)
- QUBT 19.1M
- CRNX 1.2M
- Earning Date
- QUBT 11-05-2025
- CRNX 11-11-2025
- Dividend Yield
- QUBT N/A
- CRNX N/A
- EPS Growth
- QUBT N/A
- CRNX N/A
- EPS
- QUBT N/A
- CRNX N/A
- Revenue
- QUBT $263,000.00
- CRNX $1,392,000.00
- Revenue This Year
- QUBT $23.06
- CRNX $489.51
- Revenue Next Year
- QUBT $311.11
- CRNX $661.93
- P/E Ratio
- QUBT N/A
- CRNX N/A
- Revenue Growth
- QUBT N/A
- CRNX 0.51
- 52 Week Low
- QUBT $0.64
- CRNX $24.10
- 52 Week High
- QUBT $27.15
- CRNX $62.53
- Technical
- Relative Strength Index (RSI)
- QUBT 64.93
- CRNX 62.97
- Support Level
- QUBT $15.76
- CRNX $33.42
- Resistance Level
- QUBT $17.48
- CRNX $37.23
- Average True Range (ATR)
- QUBT 1.05
- CRNX 1.48
- MACD
- QUBT 0.36
- CRNX 0.03
- Stochastic Oscillator
- QUBT 82.17
- CRNX 74.93
About QUBT Quantum Computing Inc.
Quantum Computing Inc is an integrated photonics and quantum optics technology company that provides accessible and affordable quantum machines to the world today. Its products are designed to operate at room temperature and low power at an affordable cost. The Company's portfolio of core technologies and products offer capabilities in the areas of high-performance computing, artificial intelligence, and cybersecurity, as well as remote sensing applications.
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.